RACHEL LINDQUIST: Open Payments
NPI 1790463370 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $182 · 2025 $444
Food & beverage: $389Education: $55
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $150 |
| GlaxoSmithKline, LLC. | 3 | $90 |
| AERIN MEDICAL INC. | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 1 | $55 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Surgenex LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
Products named: DUPIXENT, NUCALA, VIVAER STYLUS, SurGraft, TEZSPIRE, NEFFY.
Industry payments across AZ — which companies pay providers there.
